| |
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] |
38.32 |
| |
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia |
38.32 |
| |
RIG-I and MDA5 fRIP during KSHV lytic reactivation |
33.31 |
| |
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision |
29.94 |
| |
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] |
27.47 |
| |
ETV7 and interferon response |
26.07 |
| |
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha |
26.07 |
| |
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 |
25.44 |
| |
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] |
25.13 |
| |
Alu RNA modulates the expression of cell cycle genes in human fibroblasts |
24.13 |
| |
Genes significantly down or Up-regulated upon RNF219 knockdown |
23.86 |
| |
m6A-seq data analysis of control and PCIF1 knockdown transcriptome |
23.73 |
| |
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. |
23.44 |
| |
LNCaP treated with iBET |
22.0 |
| |
TGF-β regulation of miRNA expression in pancreatic cancer |
21.29 |
| |
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML |
21.05 |
| |
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein |
20.9 |
| |
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition |
20.8 |
| |
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') |
20.61 |
| |
The landscape of alternative splicing in aggressive prostate cancers |
20.01 |
| |
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction |
19.95 |
| |
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 |
19.91 |
| |
miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells |
19.87 |
| |
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma |
19.71 |
| |
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 |
19.68 |
| |
RNAseq Analysis in glioblastoma cells treated with Mepazine |
19.54 |
| |
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. |
19.2 |
| |
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells |
19.17 |
| |
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy |
18.92 |
| |
Role of microRNAs in the interaction between Salmonella and the host cell |
18.86 |
| |
MYCi361 regulates MYC target genes |
18.67 |
| |
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 |
18.44 |
| |
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma |
18.3 |
| |
Ribosomal footprinting of CN34-Parental and CN34-LM1a |
18.26 |
| |
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) |
18.21 |
| |
A Unique Epigenomic Landscape Defines Human Erythropoiesis |
17.87 |
| |
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) |
17.87 |
| |
RNAseq of HEK293 cells after Chtop knockdown |
17.76 |
| |
Co-transcriptional loading of RNA export factors shapes the human transcriptome |
17.76 |
| |
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy |
17.51 |
| |
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] |
17.47 |
| |
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. |
17.34 |
| |
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO |
17.31 |
| |
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion |
17.01 |
| |
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay |
16.87 |
| |
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing |
16.81 |
| |
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells |
16.76 |
| |
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells |
16.61 |
| |
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma |
16.48 |
| |
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) |
16.48 |
| |
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq |
16.15 |
| |
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] |
16.09 |
| |
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 |
15.77 |
| |
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells |
15.53 |
| |
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 |
15.24 |
| |
Atheroprotective flow alters EZH2/H3K27me3 dependent transcriptional profile in human endothelial cells |
15.18 |
| |
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death |
15.17 |
| |
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] |
15.13 |
| |
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] |
15.04 |
| |
RNAseq Study in CC-671 Treated Cal-51 Cells |
15.0 |
| |
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc |
14.96 |
| |
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells |
14.93 |
| |
Ribosomal footprinting of MDA-Parental and MDA-LM2 |
14.92 |
| |
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) |
14.78 |
| |
Nrf2 regulated genes in A549 cells |
14.74 |
| |
Identification of Nrf2 regulated genes by RNA sequencing |
14.74 |
| |
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells |
14.74 |
| |
An RNA-centric dissection of host complexes controlling flavivirus infection |
14.7 |
| |
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] |
14.7 |
| |
Human cell line and subcutaneous tumor |
14.63 |
| |
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 |
14.33 |
| |
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition |
14.3 |
| |
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] |
14.28 |
| |
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing |
14.25 |
| |
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide |
14.11 |
| |
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells |
14.04 |
| |
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines |
14.03 |
| |
Cleavage Factor Im as a key regulator of 3’ UTR length |
13.97 |
| |
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule |
13.95 |
| |
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. |
13.94 |
| |
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells |
13.93 |
| |
3’ Uridylation Expands miRNA Target Repertoire |
13.77 |
| |
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) |
13.76 |
| |
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation |
13.76 |
| |
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. |
13.68 |
| |
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression |
13.67 |
| |
The regulartory role of ZCCHC24 in splicing machinery |
13.66 |
| |
The mechanism of HHT in treating acute myeloid leukemia on RNA level. |
13.62 |
| |
Transcriptomic analysis of effect of oncolytic measles virus (MV) on transformed and non-transformed bone marrow-derived mesenchymal stem cells (MSCs) |
13.6 |
| |
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling |
13.53 |
| |
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells |
13.4 |
| |
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] |
13.4 |
| |
Differetially expressed genes after hTR overexpression in U2OS cells |
13.23 |
| |
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade |
13.22 |
| |
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma |
13.18 |
| |
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells |
13.11 |
| |
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA |
13.1 |
| |
A transcriptome dataset revealing the molecular features of breast cancer stem cells |
13.08 |
| |
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG |
13.0 |
| |
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit |
12.98 |
| |
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells |
12.96 |
| |
Pharmacologic inhibition of STAT5 in AML |
12.95 |
| |
Determination of tRNA aminoacylation levels by high throughput sequencing |
12.92 |
| |
Single-cell transcriptomics of the human placenta: inferring the cell communication network of the maternal-fetal interface |
12.89 |
| |
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles |
12.88 |
| |
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C |
12.88 |
| |
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes |
12.81 |
| |
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] |
12.75 |
| |
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock |
12.75 |
| |
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells |
12.72 |
| |
Differentially expressed vascular development genes for iPSC-ECs from CDI |
12.68 |
| |
Dtx3L and Androgen Signaling in Prostate Cancer |
12.61 |
| |
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] |
12.47 |
| |
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma |
12.41 |
| |
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] |
12.35 |
| |
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data |
12.21 |
| |
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas |
12.14 |
| |
RNAseq of PRMT4KD in human cord blood derived CD34+ cells |
12.1 |
| |
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma |
12.07 |
| |
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes |
12.07 |
| |
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq |
12.05 |
| |
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator |
11.91 |
| |
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] |
11.91 |
| |
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. |
11.83 |
| |
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. |
11.83 |
| |
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells |
11.82 |
| |
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] |
11.82 |
| |
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy |
11.77 |
| |
The MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in MLLr AML |
11.74 |
| |
Downregulation of DDX5/DDX17 and REST |
11.71 |
| |
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy |
11.7 |
| |
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression |
11.66 |
| |
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] |
11.65 |
| |
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition |
11.65 |
| |
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses |
11.62 |
| |
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling |
11.61 |
| |
Transcriptional responses of human insulinoma cells to acute cytokine exposure |
11.58 |
| |
Modeling the MYC-driven normal-to-tumour switch in breast cancer. |
11.51 |
| |
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation |
11.51 |
| |
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component |
11.29 |
| |
Differential gene expression analysis between proliferating and quiescent human dermal fibroblasts |
11.28 |
| |
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection |
11.23 |
| |
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] |
11.23 |
| |
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma |
11.17 |
| |
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia |
11.17 |
| |
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] |
11.17 |
| |
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors |
11.16 |
| |
Single-cell transcription profiling in KS1 patient iPSCs and NPCs |
11.16 |
| |
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs |
11.13 |
| |
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] |
11.06 |
| |
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis |
11.04 |
| |
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] |
11.04 |
| |
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media |
11.01 |
| |
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) |
10.99 |
| |
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide |
10.97 |
| |
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling |
10.96 |
| |
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering |
10.85 |
| |
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation |
10.84 |
| |
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls |
10.82 |
| |
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls |
10.82 |
| |
Neurofibroma |
10.81 |
| |
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines |
10.81 |
| |
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 |
10.79 |
| |
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis |
10.7 |
| |
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture |
10.64 |
| |
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells |
10.56 |
| |
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response |
10.56 |
| |
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell |
10.55 |
| |
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection |
10.55 |
| |
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression |
10.53 |
| |
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells |
10.51 |
| |
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* |
10.51 |
| |
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators |
10.5 |
| |
Gene expression profile of LMSU gastric cancer cell p53 KO and KD |
10.47 |
| |
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation |
10.41 |
| |
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) |
10.38 |
| |
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction |
10.38 |
| |
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer |
10.34 |
| |
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance |
10.31 |
| |
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer |
10.3 |
| |
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts |
10.27 |
| |
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts |
10.22 |
| |
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation |
10.21 |
| |
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor |
10.19 |
| |
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples |
10.19 |
| |
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation |
10.19 |
| |
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] |
10.17 |
| |
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference |
10.17 |
| |
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment |
10.14 |
| |
Transcriptomic analysis of the HOTAIR-regulated genes |
10.14 |
| |
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II |
10.13 |
| |
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs |
10.08 |
| |
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] |
10.08 |
| |
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis |
10.08 |
| |
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression |
10.01 |
| |
RNA-seq analysis of differentiating human erythroblasts |
10.0 |
| |
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq |
9.95 |
| |
A code of mono-phosphorylation modulates the function of RB. |
9.94 |
| |
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity |
9.93 |
| |
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture |
9.93 |
| |
Global analysis of alternative splicing regulated by RBM10 |
9.91 |
| |
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis |
9.89 |
| |
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions |
9.89 |
| |
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation |
9.88 |
| |
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture |
9.82 |
| |
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer |
9.8 |
| |
Transcription control by the ENL YEATS domain in acute leukemia |
9.79 |
| |
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] |
9.79 |
| |
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] |
9.78 |
| |
Transcriptome analysis of Zika infected neural stem cells |
9.75 |
| |
Zika infected neural stem cells |
9.75 |
| |
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC |
9.73 |
| |
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] |
9.7 |
| |
Trans-differentiation of human adult peripheral blood T cells into neurons |
9.66 |
| |
Sensing self and nonself circular RNAs |
9.63 |
| |
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype |
9.62 |
| |
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma |
9.61 |
| |
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E |
9.6 |
| |
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells |
9.59 |
| |
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. |
9.57 |
| |
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) |
9.54 |
| |
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage |
9.54 |
| |
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 |
9.51 |
| |
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging |
9.5 |
| |
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated |
9.47 |
| |
Global gene expression profile of dasatinib-resistant RCH-ACV cells |
9.44 |
| |
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors |
9.42 |
| |
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors |
9.42 |
| |
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome |
9.36 |
| |
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells |
9.35 |
| |
MYC dependent mRNA translation shapes gene expression and cell biology |
9.32 |
| |
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] |
9.32 |
| |
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] |
9.3 |
| |
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification |
9.29 |
| |
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] |
9.29 |
| |
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection |
9.28 |
| |
High-throughput sequencing of PROMPT-enriched samples. |
9.2 |
| |
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) |
9.19 |
| |
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin |
9.19 |
| |
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells |
9.19 |
| |
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] |
9.19 |
| |
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data |
9.16 |
| |
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress |
9.16 |
| |
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway |
9.15 |
| |
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine |
9.14 |
| |
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma |
9.07 |
| |
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles |
9.04 |
| |
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells |
9.03 |
| |
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation |
9.02 |
| |
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha |
8.98 |
| |
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration |
8.95 |
| |
Disruption of the exocyst induces podocyte loss and dysfunction |
8.94 |
| |
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] |
8.93 |
| |
Convergent roles of ATF3 and CSL in chromatin control of CAF activation |
8.93 |
| |
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection |
8.89 |
| |
Expression and functions of long noncoding RNAs during human T helper cell differentiation |
8.88 |
| |
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells |
8.86 |
| |
Fbxo32 mediated gene expression program underlies EMT and metastasis |
8.86 |
| |
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model |
8.86 |
| |
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells |
8.85 |
| |
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders |
8.81 |
| |
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct |
8.79 |
| |
Global Mapping of Human RNA-RNA Interactions |
8.76 |
| |
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters |
8.76 |
| |
Transcriptomic analyssis following EHMT1/2 inhibition |
8.74 |
| |
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells |
8.71 |
| |
Cerebellar differentiation in Ataxia-Telangiectasia |
8.66 |
| |
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells |
8.66 |
| |
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] |
8.66 |
| |
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence |
8.64 |
| |
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] |
8.64 |
| |
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer |
8.64 |
| |
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown |
8.63 |
| |
RNA sequencing of matched nephrectomy samples [RNA-seq] |
8.61 |
| |
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples |
8.61 |
| |
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication |
8.6 |
| |
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) |
8.59 |
| |
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development |
8.57 |
| |
Recovery and analysis of nascent RNA |
8.44 |
| |
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains |
8.44 |
| |
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 |
8.44 |
| |
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions |
8.42 |
| |
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition |
8.41 |
| |
Triple vectors expand AAV transfer capacity in the retina |
8.4 |
| |
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data |
8.4 |
| |
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML |
8.37 |
| |
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines |
8.37 |
| |
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) |
8.37 |
| |
Global analyses of the effect of different cellular contexts on microRNA targeting |
8.37 |
| |
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] |
8.36 |
| |
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells |
8.36 |
| |
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell |
8.34 |
| |
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells |
8.32 |
| |
Identification of HOXB13 target genes responsive to BET inhibitors |
8.28 |
| |
Comparative whole-transcriptomic analysis between normal and AKAP-Lbc-depleted human embryonic stem cells |
8.25 |
| |
RNA-seq of resting and activated CD4+ T cells +-JQ1 |
8.23 |
| |
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells |
8.18 |
| |
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) |
8.15 |
| |
High-efficiency RNA-based reprogramming of human primary fibroblasts |
8.14 |
| |
Efficient and quantitative high-throughput tRNA sequencing |
8.14 |
| |
Identification of Sin3B regulated genes during quiescence |
8.1 |
| |
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 |
8.09 |
| |
The impact of pro-inflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes |
8.09 |
| |
RNA-sequencing in irradiated and normal A549 cells. |
8.09 |
| |
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance |
8.05 |
| |
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment |
8.03 |
| |
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells |
8.02 |
| |
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair |
7.99 |
| |
Profiling of escape kinetics of viruses subjected to RNAi |
7.97 |
| |
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] |
7.95 |
| |
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth |
7.95 |
| |
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) |
7.95 |
| |
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit |
7.88 |
| |
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. |
7.85 |
| |
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone |
7.85 |
| |
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells |
7.83 |
| |
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines |
7.83 |
| |
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation |
7.81 |
| |
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns |
7.81 |
| |
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] |
7.8 |
| |
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis |
7.8 |
| |
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs |
7.78 |
| |
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation |
7.75 |
| |
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 |
7.73 |
| |
Splicing and epigenetic factors jointly regulate epidermal differentiation |
7.66 |
| |
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes |
7.65 |
| |
A map of gene expression in neutrophil-like cell lines |
7.64 |
| |
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF |
7.62 |
| |
Differential Protein Occupancy Profiling of the mRNA Transcriptome |
7.6 |
| |
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture |
7.58 |
| |
The Genetic Landscape of Diamond-Blackfan Anemia |
7.57 |
| |
RNA-seq of human aneuploid cell lines with Trisomy 21 |
7.54 |
| |
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells |
7.49 |
| |
EWS-Fli and LNC regulated genes in comparison to GFP samples |
7.46 |
| |
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene |
7.46 |
| |
Analysis of transcriptional regulation by Myt1 and Myt1l |
7.41 |
| |
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells |
7.38 |
| |
Human cells contain natural double-stranded RNAs with potential regulatory capacity |
7.37 |
| |
FGF2 induces migration of human bone marrow stromal cells by increasing core-fucosylations on N-glycans of integrins |
7.37 |
| |
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export |
7.32 |
| |
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells |
7.28 |
| |
Systematic discovery of endogenous human ribonucleoprotein complexes |
7.22 |
| |
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells |
7.2 |
| |
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells |
7.16 |
| |
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes |
7.16 |
| |
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development |
7.16 |
| |
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance |
7.13 |
| |
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα |
7.13 |
| |
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer |
6.96 |
| |
Ro60-knockout cells |
6.9 |
| |
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes |
6.83 |
| |
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response |
6.8 |
| |
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 |
6.74 |
| |
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] |
6.74 |
| |
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma |
6.73 |
| |
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] |
6.65 |
| |
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression |
6.65 |
| |
Gene expression from AsPC-1 cells treated with PTC596 and DMSO |
6.64 |
| |
Molecular Criteria for Defining the Naive Human Pluripotent State |
6.6 |
| |
RNA transcriptome analysis during HSV-1 infection |
6.59 |
| |
Genome-wide analysis of Dengue virus 2 infected cells |
6.51 |
| |
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation |
6.36 |
| |
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells |
6.2 |
| |
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients |
6.13 |
| |
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients |
6.13 |
| |
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control |
6.11 |
| |
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate |
6.11 |
| |
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal |
6.11 |
| |
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine |
6.1 |
| |
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells |
6.07 |
| |
RNA-seq of naive and primed ES cells |
6.05 |
| |
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells |
6.05 |
| |
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] |
6.03 |
| |
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid |
5.94 |
| |
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA |
5.87 |
| |
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer |
5.86 |
| |
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 |
5.81 |
| |
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia |
5.73 |
| |
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line |
5.69 |
| |
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML |
5.63 |
| |
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa |
5.6 |
| |
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq |
5.59 |
| |
Argonaute proteins couple chromatin silencing to alternative splicing |
5.57 |
| |
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) |
5.57 |
| |
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells |
5.55 |
| |
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] |
5.41 |
| |
RNA-seq of RKO cells with cTAZ KO or putback |
5.27 |
| |
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma |
5.21 |
| |
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] |
5.21 |
| |
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes |
4.98 |
| |
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes |
4.96 |
| |
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] |
4.96 |
| |
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential |
4.89 |
| |
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer |
4.84 |
| |
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells |
4.82 |
| |
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress |
4.81 |
| |
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] |
4.81 |
| |
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) |
4.8 |
| |
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent |
4.8 |
| |
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors |
4.63 |
| |
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. |
4.62 |
| |
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states |
4.55 |
| |
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas |
4.53 |
| |
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq |
4.48 |
| |
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] |
4.4 |
| |
The cohesin release factor WAPL restricts chromatin loop extension. |
4.4 |
| |
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells |
4.36 |
| |
HBEC-shp53-PCHD7 |
4.34 |
| |
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation |
4.31 |
| |
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol |
4.23 |
| |
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells |
4.1 |
| |
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation |
4.08 |
| |
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells |
3.99 |
| |
Conservative alteration of chromosomal expression pattern across human solid tumor types |
3.95 |
| |
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) |
3.94 |
| |
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection |
3.92 |
| |
METTL3 and WTAP |
3.89 |
| |
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) |
3.85 |
| |
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes |
3.83 |
| |
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) |
3.81 |
| |
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships |
3.81 |
| |
The DPYSL2 gene connects mTOR and schizophrenia |
3.78 |
| |
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation |
3.7 |
| |
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] |
3.7 |
| |
Human Tfh cell RNA bulk sequencing |
3.69 |
| |
Effect of BCL11B knockdown on transcriptome of human T-cell precursors |
3.67 |
| |
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection |
3.55 |
| |
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) |
3.54 |
| |
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 |
3.42 |
| |
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma |
3.39 |
| |
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line |
3.38 |
| |
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells |
3.35 |
| |
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells |
3.1 |
| |
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival |
2.91 |
| |
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] |
2.9 |
| |
Identification of renal resident macrophages across species [C1] |
2.84 |
| |
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line |
2.8 |
| |
A single-cell transcriptome atlas of the human pancreas |
2.73 |
| |
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth |
2.72 |
| |
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] |
2.6 |
| |
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines |
2.48 |
| |
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells |
2.46 |
| |
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells |
2.37 |
| |
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo |
2.2 |
| |
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates |
2.15 |
| |
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers |
1.99 |
| |
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones |
1.98 |
| |
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 |
1.98 |
| |
DAOY-Notch1/Notch2 knockout: transcriptome comparison |
1.85 |
| |
Microprocessor mediates transcription termination in long noncoding microRNA genes |
1.82 |
| |
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome |
1.8 |
| |
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK |
1.79 |
| |
RNA-Seq analysis of human colorectal cancer with liver metastasis |
1.78 |
| |
RNA-Seq of PRMT1 overexpression ECA109 cells |
1.53 |
| |
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts |
1.52 |
| |
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 |
1.49 |
| |
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy |
1.48 |
| |
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 |
1.43 |
| |
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] |
1.36 |
| |
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line |
1.29 |
| |
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia |
1.21 |
| |
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells |
1.14 |
| |
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] |
1.05 |
| |
6mer seed toxicity in viral microRNAs |
1.03 |
| |
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells |
0.95 |
| |
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells |
0.88 |
| |
CDK12 mediated transcriptional regulation in U2OS cells |
0.84 |
| |
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout |
0.81 |
| |
Modulation of nonsense-mediated decay by rapamycin |
0.76 |
| |
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling |
0.69 |
| |
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases |
0.69 |
| |
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells |
0.68 |
| |
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes |
0.68 |
| |
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) |
0.62 |
| |
Interphase condensins regulate ligand-depedent enhancer activation |
0.62 |
| |
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers |
0.56 |
| |
WNT signaling memory is required for ACTIVIN to function as a morphogen |
0.49 |
| |
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] |
0.48 |
| |
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle |
0.48 |
| |
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment |
0.46 |
| |
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] |
0.46 |
| |
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs |
0.35 |
| |
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy |
0.35 |
| |
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells |
0.34 |
| |
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] |
0.31 |
| |
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders |
0.31 |
| |
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins |
0.28 |
| |
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] |
0.25 |
| |
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway |
0.23 |
| |
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] |
0.19 |
| |
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells |
0.18 |
| |
Cell cycle dynamics of human pluripotent stem cells primed for differentiation |
0.17 |
| |
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection |
0.13 |
| |
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype |
0.12 |
| |
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells |
0.11 |
| |
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] |
0.08 |
| |
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways |
0.05 |
| |
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line |
0.04 |
| |
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line |
0.04 |
| |
Exogenous rescue of KLHL9 in SF210 cell line |
0.0 |